One is stay diversified here. You know, we have seen ... but there are many, I think Blackstone has one and many others. So as a category when you're talking about value investing.Uh, depending ...

Blackstone has rebranded its $3bn (£2.32bn) music investment business to ‘Recognition’, letting go of its former name ‘Hipgnosis’, as it prepares for new acquisitions and consolidates its ...

Blackstone has rebranded its $3bn (£2.32bn) music investment business to ‘Recognition’, letting go of its former name ‘Hipgnosis’, as it prepares for new acquisitions and consolidates its assets. This ...

We are rapidly growing here. We are the largest foreign company in the country and the largest private equity firm," he said. Reaffirming Blackstone’s confidence in India, Schwarzman described ...

Private equity firm Blackstone is selling a little less than half its stake in Indian specialty packaging and laminated tube maker EPL Ltd, marking its second partial exit move since taking control of ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Blackstone Inc., one of India’s largest landlords, is ...

Private equity giant Blackstone is going big on Japan, acquiring a majority stake in the country’s leading contract research organization, CMIC. Blackstone now owns 60% of the CRO, the New York ...

Blackstone chairman Stephen A Schwarzman announced ... giant will be starting its infra investing and credit businesses here. The firm, which has got the best returns in India globally over ...

New York-based investment giant Blackstone Inc will acquire a 40 per cent stakeholding in Kolte-Patil Developers Limited, an Indian real estate firm, for ₹1,167.03 crore, according to an ...

Blackstone Infrastructure has agreed to acquire the Safe Harbor Marinas portfolio from Sun Communities for $5.65 billion in an all-cash transaction. This acquisition marks a substantial bet by the ...

Blackstone is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private equity firms in the health needs of the nation’s aging population.